Voglibose 0.3 mg and Metformin 500 mg Tablets – VOGONIA M 0.3/500 Tablets

VOGONIA M 0.3/500 Tablets – Empowered Control for Type 2 Diabetes 

VOGONIA M 0.3/500 Tablets combine Voglibose 0.3 mg and Metformin 500 mg, offering a synergistic approach to manage Type 2 diabetes with enhanced glycemic control.

Key Benefits of  Voglibose 0.3 mg and Metformin 500 mg Tablets – VOGONIA M 0.3/500 Tablets:

Postprandial Glucose Control: Voglibose slows carbohydrate absorption, reducing sugar spikes after meals.
Improved Insulin Sensitivity: Metformin lowers hepatic glucose production and enhances peripheral glucose uptake.
 Dual Action Formula: Comprehensive blood sugar management with a single tablet.
Weight Neutral: Does not promote weight gain, ensuring better overall health.
 Well-Tolerated: Advanced formulation minimizes gastrointestinal side effects.

Indications:
 Type 2 Diabetes Mellitus
Postprandial Hyperglycemia
As Add-On Therapy to Lifestyle Modifications